Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Evansville
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Evansville, IN

Studies commonly pay $75 to $4,500 per completed study

77 clinical trials are currently recruiting participants within 30 miles of Evansville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

77studies recruiting
2+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Evansville right now

Top 25 of 77 recruiting studies, sorted by proximity — each links to its official registry page

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 1,100 participants sought
Synexus Clinical Research - Evansville — Evansville, Indiana (1.5 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06628908)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Owensboro Medical Health System ( Site 0066) — Owensboro, Kentucky (27.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06500455)

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Atrial Fibrillation N/A Interventional 276 participants sought
Deaconess Gateway Hospital — Newburgh, Indiana (7.6 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07227532)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Evansville, Indiana (1.5 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 9915 — Evansville, Indiana (1.5 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Attention-Deficit/Hyperactivity Disorder Phase 4 Interventional 286 participants sought
Qualmedica Research, LLC. — Evansville, Indiana (1.5 mi) · Sponsor: Supernus Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04781140)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung Phase 3 Interventional 830 participants sought
Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06868277)

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer Phase 3 Interventional 531 participants sought
Deaconess Midtown Hospital /ID# 282134 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07365241)

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

Lung Cancer Screening N/A Interventional 330 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: Timothy Mullett
See eligibility & contact on ClinicalTrials.gov (NCT07639255)

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Asthma Phase 2 Interventional 531 participants sought
Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky (27.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07219173)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Cardiovascular Disease Phase 3 Interventional 15,100 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07000357)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Asthma Phase 3 Interventional 138 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT05757102)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Evansville, Indiana (1.5 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07181109)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Deaconess Midtown Hospital /ID# 270572 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine Phase 3 Interventional 723 participants sought
Alliance for Multispecialty Research - Medisphere Medical Research Center — Evansville, Indiana (1.5 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06641466)

A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)

Hidradenitis Suppurativa (HS) Phase 2 Interventional 150 participants sought
Site 116 — Owensboro, Kentucky (27.3 mi) · Sponsor: Spyre Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07766005)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Heart Failure Phase 3 Interventional 11,300 participants sought
Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06677060)

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart Failure, Heart Failure With Reduced Ejection Fraction Phase 3 Interventional 1,800 participants sought
Deaconess Heart Group — Newburgh, Indiana (7.6 mi) · Sponsor: Cytokinetics
See eligibility & contact on ClinicalTrials.gov (NCT06736574)

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Moderate Aortic Valve Stenosis Phase 2, Phase 3 Interventional 1,276 participants sought
The Heart Hospital at Deaconess Gateway — Newburgh, Indiana (7.6 mi) · Sponsor: Kardigan, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07001800)

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

Asthma Phase 3 Interventional 110 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT07645248)

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis Phase 3 Interventional 510 participants sought
Nektar Investigative Site — Owensboro, Kentucky (27.3 mi) · Sponsor: Nektar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07690371)
Actively enrolling

Studies you may be able to join near Evansville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Evansville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MediSphere Medical Research Center

★ 5.0
4411 Washington Ave Ste 147, Evansville, IN 47714
(812) 471-4110
"Good people who care about there people. For medical research ."
— Troy Christian, 5★

Qualmedica Research

5015 Plaza E Blvd, Evansville, IN 47715
(812) 205-2475

Clinical trials in Evansville: what's recruiting

The Evansville area currently has 77 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Evansville, the most active research areas are:

  • Cancer & Oncology7 studies
  • Heart & Vascular5 studies
  • Lungs & Breathing3 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Evansville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Evansville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Evansville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Evansville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Evansville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Evansville, IN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Evansville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Evansville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Evansville typically complete one or two studies per year.

Paid clinical trials near Evansville

Other metros within reach

Clarksville, TN8 Louisville, KY559 Nashville, TN1,349 Champaign, IL176 Indianapolis, IN953 Murfreesboro, TN84 Lafayette, IN34 Springfield, IL188

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Evansville Bladder Issues Due To Spinal Cord Injury in Evansville All conditions

More of IN

Indianapolis953 Fort Wayne117 Elkhart105 South Bend105 Lafayette34

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts